Literature DB >> 16247190

Comparison of prostaglandin and cimetidine in protection of isolated gastric glands against indomethacin injury.

T Brzozowski1, A Tarnawski, D Hollander, S Sekhon, W J Krause, H Gergely.   

Abstract

Prostaglandins can protect the in vivo gastric mucosa against necrosis produced by a variety noxious agents. Cimetidine has also been shown to have protective properties in humans and in some models of experimental injury. Whether prostaglandins or cimetidine may protect gastric mucosal cells directly in the absence of systemic factors remains controversial. In the present study, the potential protective actions of prostaglandin and cimetidine against indomethacin injury were assessed in isolated rat gastric glands. Gastric glands were pre-incubated in oxygenated medium with either placebo, 16,16 dimethyl prostaglandin E(2) (dm PGE(2)) or cimetidine and incubated at 37 degrees C in medium containing 0.5 mg/ml of indomethacin for 2, 4 and 6 hrs. Cell injury and protection was assessed by the Fast Green exclusion test (viability test), leakage of lactate dehydrogenase (LDH) into the medium, and by scanning and transmission electron microscopy. In addition, the generation of PGE(2) by the gland cells was determined using RIA assay. Indomethacin by itself significantly reduced the viability of gastric glands, increased LDH release into the medium and produced prominent ultrastructural damage. In contrast to cimetidine, co-incubation of gastric glands with dm PGE(2) added to indomethacin, significantly reduced indomethacin-induced injury, increased the number of viable cells, reduced LDH leakage and diminished the extent of ultrastructural damage. The dose of indomethacin (5 microg/ml) which significantly inhibited the generation of PGE(2) (up to 90% inhibition) had no effect on cell viability nor LDH release. We conclude that 1) exogenous PGE2 exerts a potent protective activity in vitro which is independent on neural, vascular and hormonal factors; 2) inhibition of endogenous PGs may not the primary mechanism in the deleterious action of indomethacin against damage to gastric glandular cells and 3) indomethacin can exert a direct cytotoxic effect on the mucosal cells in gastric glands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247190

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  4 in total

Review 1.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

2.  EP4 agonist alleviates indomethacin-induced gastric lesions and promotes chronic gastric ulcer healing.

Authors:  Guang-Liang Jiang; Wha-Bin Im; Yariv Donde; Larry-A Wheeler
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

3.  Cimetidine reduces bile acid-mediated small intestinal mucosal injury in rats in vivo.

Authors:  R A Erickson
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

4.  Exogenous asymmetric dimethylarginine (ADMA) in pathogenesis of ischemia-reperfusion-induced gastric lesions: interaction with protective nitric oxide (NO) and calcitonin gene-related peptide (CGRP).

Authors:  Marcin Magierowski; Katarzyna Jasnos; Zbigniew Sliwowski; Marcin Surmiak; Gracjana Krzysiek-Maczka; Agata Ptak-Belowska; Slawomir Kwiecien; Tomasz Brzozowski
Journal:  Int J Mol Sci       Date:  2014-03-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.